Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilastatin pharmacokinetic study with cisplatin in advanced non-small cell lung cancer
jRCTs031180329Completed
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cilastatin and cisplatin in non-small cell lung cancer (NSCLC) (3 arms). Primary endpoint: Pharmacokinetics of cisplatin in combination with cilastatin. Started Dec 2019; status: completed.
02
Drugs
cilastatincisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCTs031180329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180329.